Akses terbuka Jurnal SINTA 1
Therapeutic Potential of Gut Microbiota in Hypertension: Mechanisms of Immune Modulation and Inflammation
The Indonesian Biomedical Journal · Vol. 17 No. 4 (2025) · hlm. 317–334
- ISSN
- 2085-3297, 2355-9179
- Terbit
- 2025-08-25
- Penerbit
- Secretariat of The Indonesian Biomedical Journal
- Bahasa
- en
Abstrak
Emerging evidence links gut dysbiosis to numerous ailments, including hypertension and metabolic diseases. Multi-omics techniques have revealed that hypertensive individuals exhibit distinct alterations in their gut bacterial composition and metabolite profiles. The gut microbiome influences blood pressure through several mechanisms. For instance, microbiota-derived metabolites can have beneficial effects, such as those from short-chain fatty acids (SCFAs), or detrimental ones, like trimethylamine N-oxide (TMAO). These molecules modulate downstream signaling pathways via G protein-coupled receptors or direct immune cell activation. Furthermore, dysbiosis can compromise the gut epithelial barrier, leading to systemic inflammation that activates key regulatory pathways like the renin-angiotensin-aldosterone system (RAAS), the autonomic nervous system, and the immune system. Given these connections, the gut microbiome is a promising therapeutic target for hypertension. This review explores the potential of modulating the gut microbiota to manage blood pressure, focusing on the underlying mechanisms of immune modulation, inflammation, and microbial metabolites. By focusing on the 'how' rather than the 'what' of hypertension, it is identified that immune-mediated inflammation is orchestrated by the gut microbiota, as the core mechanism driving the disease. Gut dysbiosis is triggered by environmental factors like high-salt diets, perpetuates a pro-inflammatory state that undermines the efficacy of conventional antihypertensive drugs and contributes to treatment-resistant hypertension. Consequently, modulating the gut microbiota through targeted interventions, including dietary fiber, probiotics, and fecal transplantation, might represents a critical evolution in treatment. This approach moves beyond managing symptoms to directly correcting the inflammatory dysfunction at the heart of the disease, offering a powerful strategy to complement existing therapies.KEYWORDS: hypertension, inflammation, gut microbiota, metabolite
Kata kunci
- hypertension
- gut microbiota
- gut dysbiosis
- immunomodulation
- inflammation
- microbial metabolites
- short-chain fatty acids
- trimethylamine N-oxide
- intestinal epithelial barrier
- renin-angiotensin-aldosterone system
- autonomic nervous system
- high-salt diet
- treatment-resistant hypertension
- probiotics
- fecal microbiota transplantation
- dietary fiber
- blood pressure regulation
Jaringan kolaborasi para penulis
40 penulis · 145 tautan kepenulisan bersama · 70 lintas organisasi · menampilkan 40 yang paling banyak terhubung
Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.
- Hasanuddin University
- Padjadjaran University
- PT Prodia StemCell Indonesia (Indonesia)
- Universitas Trisakti
- Udayana University
- University of Indonesia
- Universitas Airlangga
- Organisasi lain
- Organisasi berbeda
- Organisasi sama
- Afiliasi tidak diketahui
- Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
| Rekan penulis | Organisasi | Artikel bersama |
|---|---|---|
| Suryani As’ád | Hasanuddin University | 15 |
| Gatot Susilo Lawrence | Hasanuddin University | 7 |
| Ferry Sandra | Universitas Trisakti | 7 |
| Yani Lina | Hasanuddin University | 6 |
| Ilhamjaya Patellongi | Hasanuddin University | 6 |
| Irma Ruslina Defi | Padjadjaran University | 6 |
| Cynthia Retna Sartika | PT Prodia StemCell Indonesia (Indonesia) | 5 |
| Anwar Santoso | Udayana University | 4 |
| Syakib Bakri | Hasanuddin University | 4 |
| Melisa Intan Barliana | Padjadjaran University | 4 |
| Keri Lestari | Padjadjaran University | 4 |
| Teguh Ranakusuma | University of Indonesia | 3 |
| Irawan Yusuf | Hasanuddin University | 3 |
| Rima Haifa | PT Prodia StemCell Indonesia (Indonesia) | 3 |
| Trilis Yulianti | Hasanuddin University | 3 |
| Irma Rahayu Latarissa | Padjadjaran University | 3 |
| Ida Paulina Sormin | Hasanuddin University | 3 |
| Erizal Sugiono | Hasanuddin University | 3 |
| Keri Lestari Dandan | Padjadjaran University | 3 |
| Lucia Herminawati | Hasanuddin University | 3 |
| Aziiz Mardanarian Rosdianto | Padjadjaran University | 3 |
| Rina Triana | Padjadjaran University | 3 |
| Yenny Surjawan | Hasanuddin University | 2 |
| Mansyur Arief | Hasanuddin University | 2 |
| Andri Hidayat | Hasanuddin University | 2 |
| Ahmad Faried | Padjadjaran University | 2 |
| Marsetio Donosepoetro | Universitas Airlangga | 2 |
| Burhanuddin Bahar | Hasanuddin University | 2 |
| Widjaja Lukito | SEAMEO Regional Center for Food and Nutrition | 2 |
| Indriyanti Rafi Sukmawati | Hasanuddin University | 2 |
| Antonia Anna Lukito | Hasanuddin University | 2 |
| Mansyur Arif | Hasanuddin University | 2 |
| Anna Meilana | Padjadjaran University | 2 |
| Made Putra Semadhi | Padjadjaran University | 2 |
| Candra Ninghayu | Hasanuddin University | 1 |
| Cissy Bana Kartasasmita | Padjadjaran University | 1 |
| Irmansyah Irmansyah | National Research and Innovation Agency | 1 |
Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.